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Abstract: Hematopoiesis is a highly complicated biological phenomenon. Improving its
mathematical modeling and analysis are essential steps towards consolidating the common
knowledge about mechanisms behind blood cells production. On the other hand, trying to
deepen the mathematical modeling of this process has a cost and may be highly demanding
in terms of mathematical analysis. In this paper, we propose to describe hematopoiesis under
growth factor-dependent parameters as a switching system. Thus, we consider that different
biological functions involved in hematopoiesis, including aging velocities, are controlled through
multiple growth factors. Then we attempt a new approach in the framework of time-delay
switching systems, in order to interpret the behavior of the system around its possible positive
steady states. We start here with the study of a specific case in which switching is assumed to
result from drug infusions. In a broader context, we expect that interpreting cell dynamics using
switching systems leads to a good compromise between complexity of realistic models and their
mathematical analysis.
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1. INTRODUCTION
Huge number of works devoted to the study of blood
cells creation and renewing mechanisms reflects the strong
interest from mathematicians on these biological mecha-
nisms. The long list of works includes: Burns & Tannok
(1970), Mackey (1978), Bélair et al. (1995), Mahaffy et
al. (1998), Adimy & Crauste (2007), Adimy et al. (2008),
Marciniak et al. (2009), Özbay et al. (2012), Billy et al.
(2012), Avila et al. (2012), Fridman et al. (2016), Djema
et al. (2017), and Adimy et al. (2016), to name a few. The
challenging problem is to steadily extend both modeling
and analysis aspects to constantly improve our under-
standing of the complex hematopoietic system. An inter-
esting trend in the modeling of hematopoiesis highlights
the role played by growth factors (hormone-like molecules)
in the regulation of the various biological functionalities
involved in the mechanism of blood cell formation. Ideally,
growth factors manage to maintain almost quasi-constant
level of production and replenishment of blood cells in a
healthy situation. For instance, they stimulate the pro-
duction of cells to replace the diminution of their number
by natural death, after an hemorrhage, or due to blood
donation. In other situations, the body needs to react in
 This work is supported by ALMA-project on the «Analysis of
Acute Myeloid Leukemia», Paris-Saclay (France), also in part by the
PHC Bosphore 2016 France-Turkey under project numbers 35634QM
(France) and EEEAG-115E820 TÜBİTAK).
an effective manner to deal with changes in body health
(e.g. the eosinophil normal count moves from one state
to another one when facing some allergic diseases and
infections). We quote the following works that deal with
hematopoietic systems involving growth factor-dependent
parameters: Bélair et al. (1995), Mahaffy et al. (1998),
Adimy et al. (2006), Adimy & Crauste (2007), Adimy
& Crauste (2009), and, Adimy et al. (2016). It is worth
mentioning that despite of their paramount importance,
growth factors are evoked in only few works among a
large list of papers dedicated to the whole subject. The
reason behind that is quite simple: including growth-factor
dynamics notably complicates the resulting models, as well
as their analysis. Not surprisingly, the dependence of the
biological functions on growth-factors is usually neglected.
Furthermore, we can also mention that some mathematical
models with distributed delay terms are usually used to
describe hematopoiesis. It should however be pointed out
that the latter representation gives cells the ability to
divide with a high degree of freedom during their cell-
cycle. This is one of the features that we do not find in the
models with growth-factor dependent parameters in the
literature (in this case, cells are usually assumed to divide
only at one fixed moment, for the sake of simplicity).
Owing a great deal to the previously mentioned works,
we discuss in the present paper a generalized model of
hematopoiesis that includes multiple growth-factor effects.
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We complement early works in the following way:
 We consider a model with several discrete maturity
stages, where all the biological parameters, and aging
velocities, are affected by different growth-factors. In ad-
dition, we consider that cells may divide at any moment
during their cell-cycle.
 Regarding mathematical analysis, we focus on the sta-
bility properties of positive steady states, which were less
studied in the literature despite the fact that they are the
most important ones. For that, we interpret hematopoiesis
mechanisms from a different perspective: we consider the
hematopoietic system as a possibly switching one, in the
sense that growth-factors concentrations exert a form of
event-triggered control on different biological features in-
volved in the model. The latter approach is expected to
be particularly useful for introducing therapeutic control
(where drug concentrations act as growth-factors).
2. MODELING GROWTH FACTORS DYNAMICS
In Bélair et al. (1995) (and in almost all the subsequent
works), the dynamics of growth factors are governed by an
evolution equation of the form:
ėj(t) = −αjej(t) + fj (M(t)) , (1)
where ej is the concentration of a growth factor j, αj > 0,
M(t) is the total density of mature cells, fj are some
positive decreasing functions, and lim�→+∞ fj(�) = 0. In
fact, a more general expression that may also cover the
option of therapeutic action can be represented by
ėj(t) = gi(t, ej ,M(t)), (2)
where gj is a function that depends also on time. In
this case, a time-triggered switching can be modeled, for
instance, by infusing periodic doses of drugs.
In this paper, we consider five different growth factors
(i.e. j ∈ {1, . . . , 5}), each one is acting on a particular
biological function. More precisely, we study the case
where growth factors are stimulating proliferation, dif-
ferentiation (of resting and proliferating cells) and aging
velocities; while they are blocking apoptosis rates (that
is the death rate of proliferating cells). It is agreed that
the secretion of growth factors is very fast in comparison
to population cell response (i.e. regulating hormones and
cells proliferation have different time-scales). This asser-
tion is actually behind the cell dynamics models with
static biological parameters. More importantly, the previ-
ously mentioned time-scale difference allowed the study of
models where parameters depend on growth-factors that
are in a quasi-steady state (see Marciniak et al. (2009)).
For instance, since the half-life for erythropoirtins (which
are the EPO hormones that regulate erythropoiesis) is
very short compared to hematopoietic cells proliferation,
a quasi-steady state approximation to growth-factors dy-
namics described by (1) was considered in Bélair et al.
(1995). Moreover, through our modeling via systems with
possibly switching parameters, we will be able to represent
unhealthy situations where brutal changes may occur in
(1). Indeed, new biological evidences point out for instance
that unhealthy hematopoiesis may appear suddenly due
to epigenetic mutations, which can be represented as an
abnormal jump in one or multiple parameter values (e.g.
the survival of unhealthy cells as a result of an abrupt
change in apoptosis rates, or dysfunctional maturation
and the blockade in the differentiation mechanisms). In
other situations, the growth-factor concentration can be
modified through drug infusion, which induces a change
in ej (and thereby in the model parameters). The latter
situation suggests that growth-factor concentrations are
not fully determined by the feedback from mature cells M ,
as implied by (1). Therefore, as a first step, we introduce
a general model where growth factors concentrations are
governed by (2), without wondering about time-scale in
growth-factor evolution. Subsequently, we will introduce a
new interpretation in the resulting mathematical model,
where we will also consider that growth-factor concentra-
tions approach very quickly their steady states. However,
differently from works where constant biological parame-
ters are assumed for all the time, we allow growth-factors
concentrations to move from one quasi-steady state to
another one. This behavior is well-approximated by step-
like functions and it is representative of actions initiated
Fig. 1. Schematic representation of the studied model. In our interpretation, growth-factor concentration can be seen
as drugs targeting the biological parameters involved in hematopoiesis.
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by the body itself to meet its requirement, or it can
emerge from sudden therapeutic measures (drug infusions
or bone marrow transplantation), when facing some blood
disorders. Thus, by relying on this key feature, we infer
how the behavior of the different biological functionalities
will be, as discussed in the sequel.
In Figure 1, we have n different (discrete) maturity stages
as introduced in Adimy et al. (2008). The first com-
partment represents the hematopoietic stem cells (HSCs,
Figure 1) living in the bone marrow. For all i ∈ In =
{1, . . . , n}, Ri(t) is the total density of resting cells of
the i-th immature generation, while M(t), as mentioned
previously, is the total density of one type of mature cells
(e.g. white blood cells) in the bloodstream. Resting cells
may die or differentiate to other lineages (red blood cells
or platelets) at a rate 0 < δi < 1. They can also re-
enter into the proliferating stage according to a particular
function that we classically denote βi, for all i ∈ In. During
their cell-cycle, cells may die with an apoptosis rate γi,
or they can complete their mitosis (i.e. each mother cell
divides into two daughter cells). We assume that mitosis
occurs before a maximal finite age τi. At each division,
a proportion 0 < Ki < 1 of new daughter cells will
differentiate (i.e. join the next more mature stage i+1, in
the cascade of immature stages, as illustrated in Figure 1).
The remaining portion, 0 < 1−Ki < 1, will join the same
maturity level as the one of mother cells: this is known as
self-renewing process, which is necessary to maintain the
pool of cells. After n immature stages, cells are ready to
leave the bone marrow and join the blood circulation. In
this paper, we consider in addition an aging velocity vi in
the proliferating phases, as illustrated in Figure 1. Next,
and this is the key point, we consider that the growth-
factors concentrations (ej , j ∈ {1, . . . , 5}) are acting on
the biological functionalities as follows:
 δi(·) depends on e1. Increasing e1 yields to increase
δi, across all maturity levels. We also consider that
lime1→∞ δi(e1) = δi < 1, for all i ∈ In.
 βi(·, ·) is a function that depends on e2 and on the total
density of resting cells, Ri for all i ∈ In. We consider that
for each fixed e2, the mapping βi (e2, Ri) is continuously
decreasing with respect to Ri, and limRi→∞ βi(·, Ri) = 0
(see Mackey (1978)). On the other hand, for a fixed Ri,
the mapping βi (e2, Ri) is increasing when e2 increases, and
where βi(0, Ri) = 0, and lime2→∞ βi(e2, Ri) = βi > 0.
 The apoptosis rate, γi(·), depends on the concentration
e3. Since, by convention, a growth factor stimulates the
production of cells, we consider that the mapping γi(e3) is
decreasing with respect to e3.
 Differentiation, Ki(·), increases with respect to e4 and
lime4→∞ Ki(e4) = Kimax < 1.
 Similarly, the aging-velocities vi, which are affected by
the concentration e5, for all i ∈ In, are increasing from a
normal velocity-values (normalized to 1), until reaching a
maximum velocity vimax > 1.
Remark 1. On one hand, we assumed that the evolution
of growth-factor concentrations with respect to time is
approximated by step-like functions. On the other hand,
we discussed how the model parameters (Ki, γi,. . .) may
vary with respect to growth-factor concentrations (i.e.
with respect to the set of discrete values ej resulting from
the step-functions). It follows that changes in growth-
factor concentrations with respect to time exert a kind
of triggered-event control on model parameters. Thus,
by knowing the evolution of growth-factor concentrations
(e.g. predefined therapeutic protocols) we can determine
how the affected biological parameters evolve with respect
to time (an illustration is provided in Figures (a),(b) in
Table 2, with only two changing parameters γi and vi).
3. MODEL EQUATIONS
We consider that growth factors concentrations are gov-
erned by (2) and we focus now on cell dynamics. The model
described in Figure 1 is governed by an age-structured
McKendrick model with a set of boundary conditions and
suitable initial conditions (details about the PDE version
of the model are omitted here). By following Bélair et al.
(1995) (see also Foley & Mackey (2009), and the references
therein), who themselves were inspired by techniques of
Metz & Diekmann (1986) and Smith (1993), we can trans-
form the age-structured system into a time-delay system
using the method of characteristics. The obtained result is
given in Table 1, however, its exploitation in that form is
not a trivial task. Indeed, the implicitly defined variable
Ta, and the state variables that appear in the distributed
delay terms (Ri and the growth-factor concentrations e2, e3
and e5) are not easy to manipulate in order to investigate
the existence of positive steady states and their stability
properties. Now, we use the switching behavior of the
growth factors on the model parameters in order to provide
a new representation of the model given in Table 1.
 First, we start by assuming that the fourth equation
in Table 1 has a unique piecewise continuous solution for
all j ∈ {1, . . . , 5}. Whatever the behavior of the states
ej(t), for all t ≥ 0, (whether driven by a body requirement
or resulting from drug infusions), the effect on biological
functions (δi, βi, γi, Ki and vi) is similar. We recall from
Sections 1, 2 that knowing the solutions ej allows us to
determine the variation of the biological parameters with
respect to time. An illustration is provided in Figures (a-
b)-Table 2, in which we give a qualitative example with two
parameters, vi and γi (the remaining biological parameters
can be represented in a similar way). For all t ≥ 0, we
define the time duration h that corresponds to the smallest
time-interval during which all the biological parameters
(not only those represented in the corresponding Figure)
are invariant with respect to the possible change in their
respective growth-factor concentrations. Therefore, we can
distinguish between two interesting situations:
 The case h < τi: In this situation, studying the result-
ing model without extra assumptions is not an easy task.
The difficulty comes from the distributed delay terms that
may cover, in the general case, a large period of time,
involving several switches (Figure(a)-Table 2).
 The case h >> τi: This is a more suitable situation
for the analysis (see Figure(b)-Table 2). Indeed, since the
biological parameters do not vary during a sufficiently
large period of time, we can rewrite the system in Table
1 in a more convenient form, especially in the region (D3)
which is illustrated in Figure (b)-Table 2. That region
coincides with the time interval [ts1 + τi, ts2], where ts1
and ts2 are two consecutive switching time-instants. The
particularity of (D3) is that the model in Table 1 can be
rewritten as a system without switching dynamics, even
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Ṙ1(t) = − [δ1(e1(t)) + β1 (e2(t), R1(t))]R1(t) + 2 (1−K1(e4(t)))�1 (R1t, e2t, e3t, e5t) , and, for all i ≥ 2,
Ṙi(t) = − [δi(e1(t)) + βi (e2(t), Ri(t))]Ri(t) + 2 (1−Ki(e4(t)))�i (Rit, e2t, e3t, e5t)
+2Ki−1(e4(t))�i−1 (Ri−1t, e2t, e3t, e5t) ,
Ṁ(t) = −μM(t) + 2Kn(e4(t))�n (Rnt, e2t, e3t, e5t) ,
ėj(t) = −gi (t, ej(t),M(t)) , for all j ∈ {1, . . . , 5} ,













− γi (e3 (t− Ta + �)) d�
βi (e2(t− Ta), Ri(t− Ta))Ri (t− Ta) da,




vi(e5(�))d�, for all a ∈ [0, τi].
Table 1. The resulting nonlinear system with distributed delays obtained after reducing the
PDEs system describing the model in Figure 1, associated with its boundary conditions.
(a) (b)
(c) (d)
Table 2. (a) The case , where h < τi. (b) The case , where h >> τi. (c) Illustration of
the trajectory R1(t). The values R11∗ and R21∗ represent, respectively, the positive steady states
of the subsystems σ = 1 and σ = 2. The green regions B11 and B21 are the plausible regions
of attraction of, respectively, R11∗ and R21∗. (d) Equilibrium points (of interest) of the studied
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represent the different positive equilibia, for different subsystems. The red point represents the
favourable steady state that the hematopoiesis process achieves after a series of switching (e.g.
by following a therapeutic strategy).
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⎧⎪⎪⎪⎪⎪⎪⎪⎨
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inside its distributed delay terms (the corresponding model
equations are in Table 3). If a switching (in at least one
of the model parameters) occurs at a time instant ts1 > 0,
then -by definition- the next switching instant will not
occur before ts1 + h. We use the following notation: the
parameter σ ∈ N identifies which sub-system is activated
at any time instant t ≥ 0 (e.g. when at least one parameter
changes at ts1 > 0, then the system in Table 3 switches
from a sub-system σ = 1, to a sub-system σ = 2).
In the region (D3), the system is exclusively defined by
specifying σ. However, it is not the case in the region (D2)
since the distributed delay terms appeal the history of the
system in the region (D1), which complicates its analysis.
Without loss of generality, we select in Table 3 the non-
switching dynamical subsystem defined by σ = 1 to be
activated during the (D2)-(D3)- time-period, between two
consecutive switching time-instants ts1 and ts2.
 At this juncture, from the previous discussion, we
assume in our model that h >> τi (case ). In the sequel,
stability properties of our model are discussed. An inter-
esting observation is that, by focusing on the behavior of
the fixed subsystem on (D3), the portion on (D2) appears
as nothing more than the initial condition associated to
the studied sub-system.
4. STABILITY PROPERTIES OF THE FAVOURABLE
STEADY STATE
We focus on the new representation of the model as in
Table 3, where σ = 1, on the time interval t ∈ [ts1, ts1 +
h] ⊆ [ts1, ts2]. In order to determine the asymptotic be-
havior of this system, we start by assuming that no switch
will occur (i.e. ts2 → ∞). Then, one may investigate
the existence of a strictly positive steady state, Eσ=1 =�






, of the studied system. We notice also
that the origin of the system described in Tables 2-3 is
always an equilibrium point. However we are focusing on
strictly positive equilibria since they are biologically more
relevant. We refer to Adimy et al. (2008) for a complete dis-
cussion on the existence of equilibrium points for a similar
model (for vi = 1 and a fixed σ). Of course, by changing
σ, the equilibrium point Eσ = (Rσ1∗, . . . , Rσn∗,Mσ∗ ) will
change. Whether through medication or by an action of the
body, we expect that the dynamics ej (Eq.(2)) converge
to a favourable state efj , which is desired by the body
or by the therapy. The corresponding equilibrium point
(i.e. Eσf for a fixed desired σf ), is assumed to be the
red point in Figure(d)-Table 2. Now, let us come-back to
the subsystem (σ = 1) in Table 3. We assume that its
positive equilibrium, Eσ=1, exists. By classical arguments,
one can study the local stability properties of Eσ=1. We
refer to Özbay et al. (2012), for the stability analysis of
a similar system, based on Input-Output approaches and
to Djema et al. (2017), for similar results derived using a
Lyapunov approach. For a particular form of the functions
βi, a subset of the region of attraction of the positive
equilibrium is provided in Djema et al. (2017). This re-
gion is expressed as a sub-level of a Lyapunov-Krasovskii
functional (LKF) (see Hahn (1967) and Kolmanovskii &
Myshkis (1999)). Recall that the estimate of the region of
attraction quantifies the set of all initial conditions such
that the states of the system converge to the positive
equilibrium point. In the case of the present paper, we
assume that switching occurs between a finite family of
sub-systems. This situation is represented in Figure(c)-
Table 2, where a possible trajectory R1(t) is illustrated.
For σ = 2, the positive equilibrium point is denoted
R21∗. The region B21 is a representation of the region of
attraction of R21∗, that we can estimate as in Djema et
al. (2017). A first observation is that if the portion of the
trajectory R1t, for t ∈ (D2), satisfies the LKF-sublevel
condition defining the region of attraction of R21∗, then
the trajectory R1(t) converges exponentially to its positive
equilibrium point. Extra-assumptions on the model ensure
that this conditions are always satisfied (using the fact
the trajectories of the studied system are bounded), and
for sufficiently close successive equilibrium points Rσi∗ (i.e.
moderate jumps in the parameters values). Moreover, in
Özbay et al. (2012), a conjuncture was stated from numeri-
cal simulations: systems of the studied class (for each fixed
σ) seem to have a region of attraction which is much bigger
than the one rigorously provided by the LKF-approach.
In summary, we suggest that when the switching model
admits a positive solution, the behavior of the trajectories
during the (D2) periods does not impact the (D3) phases,
and the system converges to the positive equilibrium Eσ∗
if the local exponential stability conditions (see Özbay et
al. (2012), Djema et al. (2017)) are satisfied for each sub-
system σ ∈ N.
5. A NUMERICAL EXAMPLE
We give a simple example where a switching system has
three sub-systems. Each one is composed of three genera-
tions of immature cells and one generation of mature cells.
for all t ∈ [ts1 + τi, ts2] ∪ [ts2 + τi, ts2] ∪ . . .⎧⎪⎪⎪⎨
⎪⎪⎪⎩
Ṙ1(t) = − [δσ1 + βσ1 (R1(t))]R1(t) + 2 (1−Kσ1 )�σ1 (R1t) , and, for all i ≥ 2,
Ṙi(t) = − [δσi + βσi (Ri(t))]Ri(t) + 2 (1−Kσi )�σi (Rit) + 2Kσi−1�σi−1 (Ri−1t) ,
Ṁ(t) = −μM(t) + 2Kσn�σn (Rnt) ,
ėj(t) = 0, for all j ∈ {1, . . . , 5} ,
where, σ ∈ N is implicitly controled by the dynamics of ej . For instance, if we consider that, ∀t ∈ [ts1 + τi, ts1 + h]

































Table 3. The new representation of the studied system when h >> τi (case ), on the time-
intervals t ∈ [ts� + τi, ts(�+1)], � ∈ N.
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 For σ = 1:  For i = 1 : K1 = 0.05, τ1 = 1.109,
γ1 = 0.28, v1 = 1, δ1 = 0.14, and, β1(R1) = 0.51+R21 .
 For i = 2 : K2 = 0.05, τ2 = 1.2, γ2 = 0.28, v2 = 1,
δ2 = 0.26, and, β2(R2) = 11+R42 .
 For i = 3 : K3 = 0.08, τ3 = 1.36, γ3 = 0.4, v3 = 1,
δ3 = 0.35, and, β3(R3) = 31+R23 .
 For M : μ = 0.042. The positive steady state is:
E1 = (0.73867, 0.89927, 1.21625, 3.86030).
 For σ = 2: We consider that β1(R1) = 0.551+R21 , β2(R2) =
1.13
1+R42
, and, β3(R3) = 3.151+R23 . All the other parameters
are the same as for σ = 1. The positive steady state is:
E2 = (0.83677, 0.96778, 1.26532, 4.01943).
 For σ = 3: We consider that the functions β1, β2, and
β3, and the parameters δ1, δ2 and δ3 are similar to those
in σ = 2. On the other hand, we consider that in this case
we have: γ1 = 0.18, K1 = 0.06, γ2 = 0.18, K2 = 0.045,
γ3 = 0.3, and, K3 = 0.055. The positive steady state is:
E3 = (1.10952, 1.14432, 1.72306, 2.70245).
Switching from the subsystem σ = 1, to σ = 2 occurs at
t = 90, then switching from σ = 2 to σ = 3 occurs at
t = 160. The trajectories are illustrated in Figure 2.
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Fig. 2. Trajectories of the switching system in the example.
6. CONCLUDING REMARKS
This work is a step-forward in refining the analysis of
healthy and unhealthy hematopoiesis. Here we introduced
the basics of a new representation of hematopoietic pro-
cesses as a switching system, through event-triggered pa-
rameters. However, many issues remain to be addressed.
In this paper we emphasize on a particular case in which
it is assumed that the behavior of the growth factors is
known. This situation is representative of a well-defined
therapeutic protocol in which drugs are administrated.
Thus, after laying the foundation of this switching model,
future work will focus on the role of mature cells (in Eq (2))
in the control exerted on growth-factors, in order to find
out switching rules that achieve healthy hematopoiesis.
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